Hologic, Inc. $HOLX Position Boosted by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of Hologic, Inc. (NASDAQ:HOLX) by 5.0% during the 3rd quarter, Holdings Channel reports. The fund owned 451,581 shares of the medical equipment provider’s stock after purchasing an additional 21,369 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Hologic were worth $30,477,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in the business. Invesco Ltd. raised its stake in shares of Hologic by 72.5% in the 2nd quarter. Invesco Ltd. now owns 8,340,785 shares of the medical equipment provider’s stock worth $543,486,000 after buying an additional 3,505,828 shares in the last quarter. Illinois Municipal Retirement Fund boosted its stake in Hologic by 20.4% during the third quarter. Illinois Municipal Retirement Fund now owns 172,294 shares of the medical equipment provider’s stock valued at $11,628,000 after buying an additional 29,143 shares in the last quarter. K.J. Harrison & Partners Inc acquired a new position in Hologic during the second quarter worth about $1,987,000. Readystate Asset Management LP bought a new stake in Hologic in the third quarter worth about $4,161,000. Finally, New York State Common Retirement Fund lifted its holdings in Hologic by 16.3% in the 3rd quarter. New York State Common Retirement Fund now owns 142,622 shares of the medical equipment provider’s stock valued at $9,626,000 after acquiring an additional 20,000 shares during the last quarter. Institutional investors and hedge funds own 94.73% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on HOLX shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Hologic in a research note on Wednesday, January 28th. BNP Paribas Exane cut shares of Hologic from a “strong-buy” rating to a “hold” rating and set a $79.00 target price for the company. in a report on Friday, November 21st. Morgan Stanley lifted their price target on shares of Hologic from $69.00 to $76.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 11th. Argus downgraded Hologic from a “buy” rating to a “hold” rating in a research report on Monday, January 12th. Finally, Evercore cut Hologic from an “outperform” rating to an “in-line” rating and decreased their target price for the stock from $79.00 to $78.00 in a report on Monday, January 5th. Two equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $78.42.

Hologic Stock Up 0.2%

Shares of NASDAQ:HOLX opened at $75.36 on Monday. The firm has a 50 day simple moving average of $74.95 and a 200 day simple moving average of $72.16. Hologic, Inc. has a 52 week low of $51.90 and a 52 week high of $75.49. The company has a debt-to-equity ratio of 0.48, a quick ratio of 3.32 and a current ratio of 4.04. The company has a market cap of $16.82 billion, a PE ratio of 31.40, a price-to-earnings-growth ratio of 2.24 and a beta of 0.72.

Hologic (NASDAQ:HOLX) last posted its quarterly earnings data on Thursday, January 29th. The medical equipment provider reported $1.04 earnings per share for the quarter, missing the consensus estimate of $1.09 by ($0.05). The firm had revenue of $1.05 billion for the quarter, compared to analysts’ expectations of $1.07 billion. Hologic had a return on equity of 19.58% and a net margin of 13.18%.The company’s revenue for the quarter was up 2.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.87 earnings per share. As a group, research analysts expect that Hologic, Inc. will post 4.28 earnings per share for the current year.

Hologic Profile

Hologic, Inc (NASDAQ: HOLX) is a global medical technology company specializing in women’s health. Headquartered in Marlborough, Massachusetts, the company develops and manufactures diagnostic products, imaging systems and surgical solutions designed to detect, diagnose and treat diseases with a primary focus on breast and skeletal health, gynecological conditions and molecular diagnostics. Its product portfolio includes digital mammography systems, 3D mammography solutions, bone densitometry equipment and molecular assays for infectious disease and oncology applications.

Since its founding in 1985, Hologic has grown through both internal innovation and strategic acquisitions.